I think the Investor Analytics Report is very good. It provides the Board with real insight into Marten & Co’s reach and the different channels through which the Trust is being promoted and the research distributed. The Board will no doubt be impressed by the click through rate and the extent to which you are […]
Investment trust insider on HICL Infrastructure – James Carthew: HICL may wobble, won’t fall down Shares in the three largest listed infrastructure stocks – HICL (HICL), 3i Infrastructure (3IN) and International Public Partnerships (INPP) – today stand on respective premiums of 8.6%, 27% and 6.3% above net asset value (NAV). Eighteen months ago they traded at […]
Investment trust insider on Hipgnosis – James Carthew: Hipgnosis Songs sounds well in tune The brokers are back from holiday and rattling their collection tins again. Hipgnosis Songs Fund (SONG) has launched a £300 million C-share issue. SONG says it has a £1 billion pipeline of potential acquisitions and can deploy the proceeds quickly. The ambition […]
QuotedData’s Matthew Read comments on an Ecofin discount conundrum – Bargain Hunter: Strong performer since launch, but on a double-digit discount This investment trust is approaching its third birthday and has been a strong performer, but is sitting on a 12% discount. Funds and Investment Trusts September 16, 2019 by Kyle Caldwell A specialist investment trust with an attractive […]
Woodford Patient Capital Trust (WPCT) suffered a second writedown in the valuation of one of its holdings in three weeks, it was announced on Thursday (12 September). In a note to the market, WPCT confirmed that Link Fund Solutions, its authorised corporate director which is charged with valuing the portfolio of unlisted stocks, had reduced […]
Investec Wealth & Investment has accused the board of Gabelli Value Plus of not “acting proactively on behalf of shareholders” as it called for a continuation vote on the investment trust. In an open letter to the trust’s chairman, Jonathan Davie, Investec Wealth & Investment’s CIO Chris Hills said shareholders should not have to wait […]
Investment trust insider on BioPharma Credit – James Carthew: a good testing time for BioPharma Credit Last week I mentioned that the largest fund in the AIC’s three debt sectors is the £1.4 billion BioPharma Credit (BPCR), whose investment approach of lending to revenue-generating life sciences companies has attracted a large fan base, helped by an […]
Investment trust Insider on P2P and Honeycomb – James Carthew: a P2P merger with Honeycomb makes sense One of the more interesting stories that emerged over the summer came from Sky News revealing the collapse of merger talks between P2P Global Investments (P2P) and Honeycomb (HONY) investment trusts. I do not know whether there was any […]
Investment Trust Insider on Hotel Income REIT – James Carthew: hotel income fund looks worth checking into After booming in 2018, the investment companies new issue market has been much quieter this year. Nervous investors, looking over their shoulders at Brexit and slowing global growth, are sticking to tried-and-trusted names. That is frustrating if you want […]
Shares magazine looks at ‘bargain’ trusts – Seven trusts on bargain ratings: which ones to buy? We reveal the trusts trading on a steeper discount to the 12 month average… MONITORING PREMIUMS AND DISCOUNTS Many investors monitor premiums and discounts to NAV very closely as a way of spotting if there is an opportunity to buy something […]
